NGHLF
Nightingale Health Oyj - Ordinary Shares - Series B

3
Loading...
Loading...
Nightingale Health Oyj engages in the development of health data platform for healthcare service providers. Its blood analysis technology utilizes nuclear magnetic resonance and proprietary software to provide health data that links a person's lifestyle to disease risk. The company was founded by Antti Juhana Kangas, Juha Pekka Pöysä, Satu Saksman, Pasi Soininen, Teemu Pentti Suna, and Peter Würtz in 2002 and is headquartered in Helsinki, Finland.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
100

Frequently Asked Questions

What is Market Cap of Nightingale Health Oyj - Ordinary Shares - Series B?
What is the 52-week high for Nightingale Health Oyj - Ordinary Shares - Series B?
What is the 52-week low for Nightingale Health Oyj - Ordinary Shares - Series B?
What is Nightingale Health Oyj - Ordinary Shares - Series B stock price today?
What is the PE ratio of Nightingale Health Oyj - Ordinary Shares - Series B?
What is the Price-to-Book ratio of Nightingale Health Oyj - Ordinary Shares - Series B?
What is the 50-day moving average of Nightingale Health Oyj - Ordinary Shares - Series B?
How many employess does Nightingale Health Oyj - Ordinary Shares - Series B has?

Latest NGHLF News

View
No NGHLF news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.